您的位置: 首页 > 农业专利 > 详情页

THERAPEUTIC AGAINST DISEASES ASSOCIATED WITH THE DEATH OF THE CELLS OF THE ENDOTHELIUM OF THE CORNITUM, DUE TO THE CONDITION OF THE ENDOPLASMATIC RETICULUM
专利权人:
СЭНДЗЮ ФАРМАСЬЮТИКАЛ КО., ЛТД. (JP);КИОТО ПРИФЕКЧУРАЛ ПАБЛИК ЮНИВЕРСИТИ КОРПОРЭЙШН (JP);ДЗЕ ДОСИСА (JP)
发明人:
КОИЗУМИ Норико (JP),ОКУМУРА Наоки (JP),КИНОСИТА Сигеру (JP)
申请号:
RU2016121150
公开号:
RU2016121150A
申请日:
2014.10.30
申请国别(地区):
RU
年份:
2017
代理人:
摘要:
The present invention provides a treatment drug or prophylactic drug for diseases, disorders, or conditions related to endoplasmic reticulum (ER) stress. Specifically, the present invention provides a treatment drug or prophylactic drug for diseases, disorders, or conditions related to endoplasmic reticulum (ER) stress in the corneal epithelium, the drug containing a TGF²-signal inhibitor. As a preferred TGF²-signal inhibitor, the drug contains 4-[4-(1,3-benzodioxole-5-yl)-5-(2-pyridinyl)-1H-imidazole-2-yl]benzamide.
来源网站:
中国工程科技知识中心
来源网址:
http://www.ckcest.cn/home/

意 见 箱

匿名:登录

个人用户登录

找回密码

第三方账号登录

忘记密码

个人用户注册

必须为有效邮箱
6~16位数字与字母组合
6~16位数字与字母组合
请输入正确的手机号码

信息补充